Sorafenib

«Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.» (wikipedia)

  • Has Subnodes:

Pathways of Sorafenib

Textual paths of Biolinks with Validity Score > 3.0
Calculate
Uses in-app credits Help
This tool shows paths like: A B C Sorafenib

Mindmaps

Visualisation of logical biolinks between drugs, supplements, symptoms etc..

MoreVitaminovPRO ranked added it 1 year ago on May 25, 2019
BioMindmap is the most convenient place to prove a medical statement and connect it with others.